Picture of ASKA Pharmaceutical Holdings Co logo

4886 ASKA Pharmaceutical Holdings Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSmall CapSuper Stock

Annual cashflow statement for ASKA Pharmaceutical Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoTanshinYuhoYuho
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,8839013,5756,1635,357
Depreciation
Amortisation
Non-Cash Items-549298-210-2,485-387
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,651-5,453-187-3,721-4,747
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,504-4936,5402,8423,350
Capital Expenditures-15,723-2,264-1,104-2,377-746
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items943-663-1,7629,120-380
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-14,780-2,927-2,8666,743-1,126
Financing Cash Flow Items-90-2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities13,036-392-455-2,996-1,820
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash760-3,8123,2196,589402